Rigorous Trial Design Is Essential to Understand the Role of Opioid Receptors in Ketamine's Antidepressant Effect
- PMID: 31042274
- DOI: 10.1001/jamapsychiatry.2019.0766
Rigorous Trial Design Is Essential to Understand the Role of Opioid Receptors in Ketamine's Antidepressant Effect
Comment in
-
Rigorous Trial Design Is Essential to Understand the Role of Opioid Receptors in Ketamine's Antidepressant Effect-Reply.JAMA Psychiatry. 2019 Jun 1;76(6):658-659. doi: 10.1001/jamapsychiatry.2019.0763. JAMA Psychiatry. 2019. PMID: 31042270 No abstract available.
Comment on
-
Association of Combined Naltrexone and Ketamine With Depressive Symptoms in a Case series of Patients With Depression and Alcohol Use Disorder.JAMA Psychiatry. 2019 Mar 1;76(3):337-338. doi: 10.1001/jamapsychiatry.2018.3990. JAMA Psychiatry. 2019. PMID: 30624551 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical